| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.002 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.003 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.17 | 0.004 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.004 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |